Johnson & Johnson and its subsidiaries have approximately 126,400 employees engaged in the research and development, manufacture, and sale of a broad range of products in the health care field. The company is organized into three business segments: consumer, pharmaceutical, and medical devices, which allows for operational flexibility and adaptation to market demands. The executive committee oversees the strategic operations and resource allocation, ensuring that the company can respond effectively to external pressures and maintain its competitive advantage. Management believes that its strategic operating principles, including a decentralized management approach and a commitment to long-term growth, are crucial for sustaining market leadership and enabling resilience in rapidly evolving markets. The company invests significantly in research and development, with $9.1 billion allocated in 2016, reflecting a commitment to innovation and the development of high-quality products that meet evolving health care needs. This investment supports the company's ability to absorb strain and preserve functioning despite adversity, thereby enhancing organizational resilience. The decentralized management approach, combined with leveraging extensive resources, positions the company well to innovate and execute strategic plans globally while addressing local market challenges. The company’s long-term growth drivers focus on creating value through innovation and expanding global reach, which are essential for maintaining organizational health and performance under pressure. The company also emphasizes the importance of maintaining a purpose-driven organization and developing global business leaders to achieve growth objectives. In response to environmental disruptions, the company has implemented restructuring actions in its medical devices segment, expected to yield annualized pre-tax cost savings, providing added flexibility and resources to fund new growth opportunities. The company’s commitment to cost management and operational efficiency is evident in its strategic initiatives, which aim to sustain profitability and support organizational survival during adverse conditions. The company’s ability to manage risks associated with economic challenges, such as those in southern European markets, demonstrates its resilience strategies and preparedness for unexpected situations. Johnson & Johnson continues to monitor economic conditions and take appropriate actions to mitigate risks, ensuring that it can confront challenges and sustain its operations effectively. The company’s focus on collaborative networks and stakeholder engagement further enhances its organizational capabilities, allowing it to adapt to complex situations and maintain a trajectory of positive adjustment amidst adversity. Through its strategic planning and investment in human capital, the company aims to foster an environment conducive to innovation and resilience, ensuring its ability to thrive in turbulent markets.